{
  "slug": "parexel-international",
  "name": "Parexel International Corp.",
  "description": "Parexel is one of the world's largest clinical research organizations, providing a full range of Phase I to IV clinical development services. They leverage extensive clinical, regulatory, and therapeutic expertise with a patient-first approach to design and deliver efficient and impactful clinical trials globally.",
  "url": "https://optimly.ai/brand/parexel-international",
  "websiteUrl": "https://parexel.com/",
  "logoUrl": "https://logo.clearbit.com/parexel.com",
  "baiScore": 41,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Clinical Research Organization",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:03:06.407Z",
  "verifiedVitals": {
    "website": "https://parexel.com",
    "headquarters": "Not specified in the provided text.",
    "pricing_model": "Not explicitly mentioned, but implied to be service-based contracts for clinical trial management and development.",
    "core_products": "Full range of Phase I to IV clinical development services, including clinical, regulatory, and therapeutic expertise.",
    "key_differentiator": "Patient-first approach ('with patients in mind', 'make clinical research a care option for anyone, anywhere'), deep therapeutic expertise (e.g., I&I specialists), global reach with extensive sites, and commitment to agile, precise, and caring trial design and execution.",
    "target_markets": "Biopharmaceutical leaders and clinical trial sites globally, aiming to serve patients in need of new treatments.",
    "employee_count": "More than 24,000 global professionals; I&I team is 13,100+ strong.",
    "subcategory": "Full-service CRO"
  },
  "intentTags": {
    "problemIntents": [
      "In-house Clinical Development: Biopharmaceutical companies could manage clinical trials entirely with their internal teams, including regulatory affairs, trial design, site management, data collection",
      "Specialized Clinical Consulting Firms: Companies might opt for smaller, specialized consulting firms for specific aspects of clinical trials, such as regulatory submissions, statistical analysis, or p",
      "Limited or Delayed Drug Development: Without a CRO or robust internal capabilities, drug development efforts could be significantly limited, delayed, or fail to meet regulatory standards, preventing n"
    ],
    "solutionIntents": [
      "Parexel clinical research organization",
      "CRO services Phase I to IV",
      "inflammation and immunology clinical trials",
      "biopharmaceutical drug development",
      "patient-centric clinical trials",
      "Clinical Trial Management Software (CTMS): Instead of outsourcing, companies could license and implement various clinical trial management systems, Electronic Data Capture (EDC) systems, and other sof"
    ],
    "evaluationIntents": []
  },
  "businessProfileClaims": [],
  "timestamp": 1786584397397
}